TRIM21/SSA1 ELISA Kit (Colorimetric) Summary
SS-A 52 Ab ELISA Kit is an indirect solid phase ELISA for the quantitative measurement of IgG class autoantibodies to SS-A 52 in human serum or plasma.
6.3 to 100 U/mL
0.5 U/mL
Sandwich ELISA
CV% < 1.1-6.4%
CV% < 2.6-3.6%
10 uL
ELISA Kit (Colorimetric)
TRIM21
Applications/Dilutions
Useful for quantification.
Packaging, Storage & Formulations
Store at 4°C.
Kit Components
- Control positive (1) and negative (2), containing SS-A 52 antibodies in a serum/buffermatrix (PBS, BSA, detergent, NaN3 0.09%), yellow, Ready to use. The concentration isspecified on the certificate of analysis.
- Calibrators A-F (0, 12.5, 25, 50, 100, 200 U/mL), containing SS-A 52 antibodies in aserum/buffer matrix (PBS, BSA, detergent, NaN3 0.09%), yellow. Ready to use.
- Divisible microplate consisting of 12 modules of 8 wells each. Ready to use.
- Wash solution, containing Tris, detergent, preservative NaN3 0.09%; 50x concentrated.
- TMB substrate, containing 3,3’,5,5’-Tetramethylbenzidin, colorless. Ready to use.
- Stop solution, contains acid. Ready to use.
- Sample buffer P, containing PBS, BSA, detergent, preservative NaN3 0.09%, yellow,concentrate (5x).
Notes
Quality control test: Standard curve.
This product is produced by and distributed for Abnova, a company based in Taiwan.
Alternate Names for TRIM21/SSA1 ELISA Kit (Colorimetric)
- 52 kDa ribonucleoprotein autoantigen Ro/SS-A
- 52 kDa Ro/SSA
- E3 ubiquitin-protein ligase TRIM21
- EC 6.3.2.-
- RNF81
- RNF81RING finger protein 81
- ro(SS-A)
- Ro52
- RO52SS-A
- Sicca syndrome antigen A
- Sjoegren syndrome type A antigen
- Sjogren syndrome antigen A1 (52kDa, ribonucleoprotein autoantigen SS-A/Ro)
- SSA1
- SSA1SSA
- TRIM21
- tripartite motif containing 21,52 kDa Ro protein
- tripartite motif-containing 21
- Tripartite motif-containing protein 21
Limitations
This product is for research use only and is not approved for use in humans or in clinical diagnosis. ELISA Kits are guaranteed for 6 months from date of receipt.
product targets : Vasopressin Receptor inhibitors